Your cart is empty
Browse transcripts and add items to get started.
SABIC delivered a sharp EBITDA recovery in Q1 2026, with adjusted EBITDA rising 25% quarter-on-quarter to $1.1 billion and margins expanding 400 basis points to 15.9%, despite revenue declining 6% to $7.0 billion on lower volumes. The quarter underscored management's pivot from scale to value-driven profitability, supported by transformation execution and disciplined cost control.
Performance Highlights
SABIC reported Q1 2026 revenue of $7.0 billion, down 6% quarter-on-quarter as a 13% decline in total sales volumes to 9.6 million metric tons — driven by Strait of Hormuz disruptions, plant maintenance, and seasonality — more than offset a 7% improvement in average selling prices. Despite the revenue shortfall, adjusted EBITDA beat expectations at $1.1 billion, up 25% from $0.9 billion in Q4 2025, with the adjusted EBITDA margin expanding 400 basis points to 15.9%, while adjusted net income swung to $218 million from a $373 million loss the prior quarter.
The single most important operating driver was price-led margin recovery, with supply-chain disruptions around the Strait of Hormuz paradoxically tightening regional product availability and lifting petrochemical and fertilizer prices. Petrochemicals EBITDA rose 28% quarter-on-quarter to $630 million on 6% higher prices despite an 8.2 MMT volume base, Agri-Nutrients EBITDA climbed 20% to $367 million on 13% urea price increases, and Specialties EBITDA jumped 38% to $118 million, supported by resilient demand in AI-linked electronics and mobility applications.
Management Outlook and Forward Catalysts
Management reaffirmed its 2030 transformation target of $3.0 billion in recurring EBITDA impact, with $220 million delivered in Q1 alone at a 61% cost-excellence and 39% value-creation split, while maintaining 2026 capital investment guidance of $3.5–$4.0 billion and targeting closure of both the European Petrochemicals and Americas/Europe ETP divestitures in Q3 and Q4 2026 respectively. The 54% urea capacity expansion approval and 98%-complete SABIC Fujian complex in China signal that selective growth is accelerating into structurally advantaged positions.
The central investor debate heading into Q2 is whether Hormuz-driven price premiums are durable or will reverse sharply on any geopolitical de-escalation, erasing the margin tailwind that drove the Q1 beat. Bulls will watch sustained tight petrochemical supply in Asia, transformation realization momentum, and divestiture proceeds recycling into returns; bears will focus on the ongoing force majeure on liquid chemicals, structurally elevated freight and war-risk insurance costs, and industrywide overcapacity that continues to compress baseline petrochemical margins.
Adjusted EPS vs. consensus breakdown — primary performance driver, segment revenue contribution, and gross margin trajectory relative to prior guidance...
Segment-by-segment revenue analysis, margin profile, and management commentary on demand trajectory vs. consensus range expectations...
Forward guidance implications for the sector, supply chain read-throughs, and investment implications for the broader competitive landscape...